EGFR has been demonstrated to regulate epithelial tissue development and homeostasis in a variety of types of cancer, including breast cancer (Sigismund et al., 2018), with approximately half of triple-negative breast cancer and inflammatory breast cancer cases overexpressing EGFR (Masuda et al., 2012). Here, EGFR is linked to cancer.